Li Feng
-
- Epigenetics and DNA Methylation 4
- Fibroblast Growth Factor Research 3
- Kruppel-like factors research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Esophageal Cancer Research and Treatment 4
-
- Lung Cancer Treatments and Mutations 4
-
- Adenosine and Purinergic Signaling 4
-
- Plant-Microbe Interactions and Immunity 3
Li Feng
37 papers receiving 341 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 181
- Pollution 29
- Molecular Medicine 10
- Radiology, Nuclear Medicine and Imaging 44
- Industrial and Manufacturing Engineering 15
Countries citing papers authored by Li Feng
This map shows the geographic impact of Li Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Feng more than expected).
Fields of papers citing papers by Li Feng
This network shows the impact of papers produced by Li Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Feng. The network helps show where Li Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 0 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 25 | |
| 12 | 2023 | 12 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 11 | |
| 15 | 2017 | 3 | |
| 16 | 2015 | 15 | |
| 17 | 2015 | 5 | |
| 18 | 2013 | 3 | |
| 19 | Cloning associated special genes in gastric cancer of North Sichuan Area | 2011 | 2 |
| 20 | 2007 | 43 |
About Li Feng
Li Feng is a scholar working on Physiology, Obstetrics and Gynecology and Oncology, having authored 46 papers that have together received 348 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers), Epigenetics and DNA Methylation (4 papers), Adenosine and Purinergic Signaling (4 papers), Fibroblast Growth Factor Research (3 papers), Plant-Microbe Interactions and Immunity (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Kruppel-like factors research (3 papers). The work is most often cited by research in Molecular Biology (181 citations), Pollution (29 citations) and Molecular Medicine (10 citations). Li Feng has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Wenjing Zhu, Xiao‐Yun Wang, Qing‐Yun Wu, Jian Zhang, Jun Luo, Ashraf Amanullah, Terry M. Hudson, Jiawei Yang, Xiao Cheng and Lu Gan. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.